Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MDG

Meridian Gold (MDG)

Meridian Gold
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:MDG
DateTimeSourceHeadlineSymbolCompany
01/27/20143:23AMGlobeNewswireMedigene acquires Trianta ImmunotherapiesNYSE:MDGMeridian Gold
01/27/20143:22AMGlobeNewswireMedigene übernimmt Trianta ImmunotherapiesNYSE:MDGMeridian Gold
12/18/20131:30AMGlobeNewswireMedigene's drug Veregen® launched in Norway and SwedenNYSE:MDGMeridian Gold
12/18/20131:30AMGlobeNewswireMedigenes Medikament Veregen® kommt in Norwegen und Schweden auf den MarktNYSE:MDGMeridian Gold
12/13/20131:30AMGlobeNewswireMedigene Granted Additional Patent for RhuDex® for the Treatment of Autoimmune DiseasesNYSE:MDGMeridian Gold
12/13/20131:30AMGlobeNewswireMedigene erhält weiteres europäisches Patent für Autoimmun-Medikamentenkandidaten RhuDex®NYSE:MDGMeridian Gold
12/11/20131:30AMGlobeNewswireMedigene announces Veregen® to be launched in the Czech Republic, Poland, Hungary, and SlovakiaNYSE:MDGMeridian Gold
12/11/20131:30AMGlobeNewswireMedigene kündigt Markteinführung von Veregen® in Tschechien, Polen, Ungarn und der Slowakei anNYSE:MDGMeridian Gold
12/05/20131:31AMGlobeNewswireTaurus becomes new marketing partner for Medigene's drug Veregen® in GermanyNYSE:MDGMeridian Gold
12/05/20131:30AMGlobeNewswireTaurus wird neuer Partner für Medigenes Medikament Veregen® in DeutschlandNYSE:MDGMeridian Gold
11/08/20131:30AMGlobeNewswireMedigene reports financial results for the first nine months of 2013NYSE:MDGMeridian Gold
11/08/20131:30AMGlobeNewswireMedigene veröffentlicht 9-Monats-Finanzbericht 2013NYSE:MDGMeridian Gold
10/01/20131:30AMGlobeNewswireMedigene announces market launch of Veregen® in TaiwanNYSE:MDGMeridian Gold
10/01/20131:30AMGlobeNewswireMedigene gibt Markteinführung von Veregen® in Taiwan bekanntNYSE:MDGMeridian Gold
09/10/20131:30AMGlobeNewswireMedigene's Drug Veregen® receives market approval in CanadaNYSE:MDGMeridian Gold
09/10/20131:30AMGlobeNewswireMedigenes Medikament Veregen® erhält Zulassung für KanadaNYSE:MDGMeridian Gold
08/21/20131:31AMGlobeNewswireMedigene to implement 4:1 share capital reduction effective 3 September 2013NYSE:MDGMeridian Gold
08/21/20131:30AMGlobeNewswireMedigene vollzieht angekündigte 4:1 Kapitalherabsetzung mit Wirkung zum 3. September 2013NYSE:MDGMeridian Gold
08/09/20131:30AMGlobeNewswireMedigene veröffentlicht 6-Monats-Finanzbericht 2013NYSE:MDGMeridian Gold
08/09/20131:30AMGlobeNewswireMedigene reports financial results for the first 6 months of 2013NYSE:MDGMeridian Gold
08/06/20131:31AMGlobeNewswireMedigene and Difa Cooper enter into agreement for the commercialization of Veregen® in ItalyNYSE:MDGMeridian Gold
08/06/20131:30AMGlobeNewswireMedigene und Difa Cooper vereinbaren Partnerschaft zur Vermarktung von Veregen® in ItalienNYSE:MDGMeridian Gold
07/29/20131:30AMGlobeNewswireMedigene AG: Markteinführung von Veregen® in Niederlanden gestartetNYSE:MDGMeridian Gold
07/29/20131:30AMGlobeNewswireMedigene AG: Market launch of Veregen® in the Netherlands startedNYSE:MDGMeridian Gold
07/17/20139:58AMGlobeNewswireMedigene Reports Outcome of Annual General MeetingNYSE:MDGMeridian Gold
07/17/20139:58AMGlobeNewswireMedigene berichtet über Ergebnisse der HauptversammlungNYSE:MDGMeridian Gold
06/05/20132:03AMGlobeNewswireMedigene plant Herabsetzung des Grundkapitals sowie Verkleinerung und Neuwahl des AufsichtsratsNYSE:MDGMeridian Gold
06/05/20132:03AMGlobeNewswireMedigene announces capital reduction and nomination of new members to a reduced Supervisory BoardNYSE:MDGMeridian Gold
06/04/20132:00AMGlobeNewswireMedigene's drug Veregen® receives market authorization notification in TaiwanNYSE:MDGMeridian Gold
06/04/20132:00AMGlobeNewswireMedigenes Medikament Veregen® erhält Zulassung für TaiwanNYSE:MDGMeridian Gold
 Showing the most relevant articles for your search:NYSE:MDG